PRESS RELEASE:
Leading State Attorneys General Discuss Enforcement in the Pharmaceutical Sector
  • Sponsored by Pharmaceutical Compliance Forum
  • November 14 - 17, 2004
  • Renaissance Marriott Hotel, Washington DC
  • www.PharmaCongress.com
PRESS RELEASE
Contact: Paul Tunnecliff
Phone: 800-684-4549
Email: registration@hcconferences.com
Website: www.PharmaCongress.com

WASHINGTON DC USA -- HEALTHCARE UPDATE NEWS SERVICETM -- OCTOBER 25, 2004: The Fifth Annual Pharmaceutical Regulatory and Compliance Congress, www.PharmaCongress.com, November 14 - 17, 2004, in Washington DC will feature a panel discussion by representatives of leading state attorneys general regarding investigations and enforcement activities relating to the pharmaceutical industry.

STATE ATTORNEYS GENERAL ENFORCEMENT ACTIVITIES IN THE PAHRMACEUTICAL SECTOR:

On Tuesday, November 16, 2004, the Pharma Congress will feature a discussion of the State Attorneys General Perspective on Pharmaceutical Consumer Protection and Regulatory Issues by the following national experts:
  • Meredyth Andrus, Esq., Antitrust Division, Office of the Attorney General of Maryland, Baltimore, MD
  • Julie Brill, Esq., Assistant Attorney General, Office of the Attorney General of Vermont, Montpelier, VT
  • James A. Donahue, III, Esq., Chief Deputy Attorney General, Office of the Attorney General of Pennsylvania, Harrisburg, PA
  • Shirley Stark, Esq., Assistant Attorney General, Office of the Attorney General of New York, New York, NY
KEYNOTE SPEAKERS:

Lester M. Crawford, DVM, PhD
Acting Commissioner of Food and Drugs, Food and Drug Administration, Rockville, MD

Michael Friedman, MBA
President and Chief Executive Officer, Purdue Pharma LP, Stamford, CT

Alan F. Holmer
President and Chief Executive Officer, Pharmaceutical Research and Manufacturers of America, Washington, DC

John K. Iglehart
Founding Editor, Health Affairs, National Correspondent, New England Journal of Medicine, Washington, DC

Mark B. McClellan, MD, PhD
Administrator, Centers for Medicare & Medicaid Services, Former Commissioner of Food and Drugs, Food and Drug Administration, Washington, DC

Lewis Morris, Esq.
Chief Counsel, Office of Inspector General, Department of Health and Human Services, Washington, DC

James Sheehan, Esq.
Associate United States Attorney, U.S. Attorney's Office for the Eastern District of Pennsylvania, Philadelphia, PA

Gene Thirolf, Esq.
Director Office of Consumer Litigation Civil Division, United States Department of Justice, Washington, DC

The Honorable Tommy Thompson (Invited)
Secretary, Department of Health and Human Services, Washington, DC

Daniel E. Troy, Esq.
Chief Counsel, Office of the General Counsel, Food and Drug Administration, Rockville, MD

Christopher Viehbacher
President, US Pharmaceuticals, GlaxoSmithKline, Research Triangle Park, NC

Susan Winkler, Esq.
Assistant United States Attorney, Deputy Health Care Fraud Chief, United States Attorney's Office for the District of Massachusetts, Boston, MA

CONGRESS CO CHAIRS:

Arjun Rajaratnam, Esq.
Vice President and Compliance Officer - Global Pharmaceuticals, GlaxoSmithKline, Research Triangle Park, NC

Brenton L. Saunders, JD, MBA
Senior Vice President, Global Compliance and Business Practices, Schering-Plough Corporation, and Past President, Health Care Compliance Association, Founder, International Association of Privacy Professionals, Kenilworth, NJ

Bert Weinstein, Esq.
Vice President, Corporate Compliance, Purdue Pharma LP, Stamford, CT

FEATURED FACULTY:

Ted Acosta, J.D.
Pharmaceutical Compliance Investigative & Dispute Services, Ernst & Young LLP, Former OIG Senior Counsel, New York, NY

Meredyth Andrus, Esq.
Antitrust Division, Office of the Attorney General of Maryland, Baltimore, MD

Scott Applebaum, Esq.
Senior Counsel, US Medicines & Medical Imaging, Bristol Meyers Squibb Company, Plainsboro, NJ

Valli Baldassano, Esq.
Vice President, Global Compliance, Commercial Operations, Schering-Plough, Kenilworth, NJ

Ben Barrameda, CPA, MBA, Esq.
Senior Manager, Deloitte & Touche, New York, NY

Bill Baxter
Director, Medicaid Market and Rebate Management, Johnson & Johnson, New Brunswick, NJ

Mary Bennett, BSPharm
Vice President, Ethical Leadership Group, Mundelein, IL

John Bentivoglio, Esq.
Partner, King & Spalding LLP, Former Special Counsel for Health Care Fraud, Chief Privacy Officer, United States Department of Justice, Washington, DC

Paul R. Berger
Associate Director, Division of Enforcement, Securities and Exchange Commission, Washington, DC

Link Bonforte
Vice President, Government Affairs, Policy and Compliance, ConvaTec, Skillman, NJ

Michael M. Breggar
Global Director, Life Sciences Practice, Life Sciences and Healthcare Regulatory, Deloitte & Touche LLP, Glen Mills, PA

Julie Brill, Esq.
Assistant Attorney General, Office of the Attorney General of Vermont, Montpelier, VT

Mary Devlin Capizzi, Esq.
Partner, Gardner Carton & Douglas, Washington, DC

Peter Claude
Partner, Pharmaceutical Advisory Services Group, PricewaterhouseCoopers, LLP, Florham Park, NJ

Daniel Connolly
Managing Partner, Giuliani Partners, New York, NY

Stanley W. Crosley, Esq.
Chief Privacy Officer, Eli Lilly and Company, Law Division, Indianapolis, IN

Gregory Crouse, CPA
Partner, Pharmaceutical Compliance Investigative & Dispute Services, Ernst & Young LLP, Tampa, FL

Teri Crouse, Esq.
Director of Compliance for Healthcare and Marketing, Eli Lilly and Company, Indianapolis, IN

James A. Donahue, III, Esq.
Chief Deputy Attorney General, Office of the Attorney General of Pennsylvania, Harrisburg, PA

Hugh M. Donnelly
Vice President, Internal Audit, Pfizer Inc., New York, NY

Andrea M. Esposito
Managing Director, Standard & Poor's Governance Services, New York, NY

Anthony Farino
Partner, Pharmaceutical Advisory Services Group, PricewaterhouseCoopers LLP, Chicago, IL

Alice S. Fisher, Esq.
Partner, Latham & Watkins, Former, Deputy Assistant Attorney General, United States Department of Justice, Washington, DC

William T. Fitzgerald, Esq.
Director, Global Compliance, Alcon Laboratories, Inc., Fort Worth, TX

Dean Forbes, JD
Director of Corporate Privacy, Schering-Plough Corp., Former Senior Attorney, Federal Trade Commission, Kenilworth, NJ

Bernard J. Ford
Industry Leader, Pharmaceutical Compliance Investigative & Dispute Services, Ernst & Young LLP, Chicago, IL

John Ford
Minority/Democratic Staff, Energy and Commerce Committee, United States House of Representatives, Washington, DC

Gary Giampetruzzi, Esq.
Compliance Counsel, Pfizer Inc., New York, NY

Wendy C. Goldstein, Esq.
Partner, Epstein, Becker & Green, PC, New York, NY

Thomas M. Greene, Esq.
Greene and Hoffman, Boston, MA

Ronald Guido
Director, Worldwide Regulatory Strategy, Pfizer Inc., New York, NY

Gerald M. Hinkley, Esq.
Partner, Davis Wright Tremaine, San Francisco, CA

Robert G. Homchick, Esq.
Partner and Chair, Health Law Group, Davis Wright Tremaine, Seattle, WA

Patric Hooper, Esq.
Principal, Hooper, Lundy and Bookman, Los Angeles, CA

Carol Suchit Hudson
Manager, Quality Assurance & Security, Johnson & Johnson Health Care Systems, Piscataway, NJ

Margaret (Peg) Hutchinson, Esq.
Assistant United States Attorney, United States Attorney's Office, Eastern District of Pennsylvania, Philadelphia, PA

David Israelite, Esq.
Deputy Chief of Staff and Counselor to the Attorney General, Chairman, Intellectual Property Task Force, United States Department of Justice, Washington, DC

Paul Kalb, JD, MD
Partner, Sidley, Austin, Brown and Wood, Washington, DC

Jonathon Kellerman
Director, Pharmaceutical Advisory Services Group, PricewaterhouseCoopers, LLP, Philadelphia, PA

Mark Allen Kleiman, Esq.
Lawyer, Law Offices of Mark Allen Kleiman, Los Angeles, CA

James Harlan Koenig, Esq.
Practice Co-Leader, Privacy Strategy & Compliance, PricewaterhouseCoopers, LLP, Philadelphia, PA

Richard P. Kusserow
President, Strategic Management Systems, Inc., Former Inspector General, Department of Health & Human Services, Alexandria, VA

Arthur Levine, Esq.
Partner, Arnold & Porter, Former Deputy General Counsel for Litigation, Food and Drug Administration, Washington, DC

Elizabeth A. Lewis, Esq.
Associate General Counsel, Commercial Millenium Pharmaceuticals, Inc., Cambridge, MA

Karen Lines, Esq.
Associate General Counsel, Genentech, South San Francisco, CA

Robert Lively
Staff Vice President, Federal Government Affairs, Schering-Plough Corporation, Washington, DC

Gregory M. Luce, Esq.
Partner, Jones Day, Former Assistant Attorney General, Commonwealth of Virginia, Washington, DC

Joan M. Macaulay, Esq.
Associate, Sidley Austin Brown & Wood LLP, Washington, DC

Kate N. Maloney
Manager, Pharmaceutical Industry Advisory Services, PricewaterhouseCoopers, LLP, Philadelphia, PA

Benjamin S. Martin, Esq.
Associate, Arnold & Porter, Washington, DC

Carolyn McElroy, Esq.
Member Health, Mintz Levin Cohn Ferris Glousky & Popeo, Former Director Maryland Medicaid Fraud Control Unit, Washington, DC

Alan McEmber
Director, Worldwide Regulatory Strategy, Pfizer Inc., New York, NY

Stephen Meagher, Esq.
Partner, Phillips & Cohen, San Francisco, CA

Jody Ann Noon, RN, JD
Principal, National Life Science Regulatory Practice Leader, Deloitte & Touche, New York, NY

Brien T. O'Connor, Esq.
Partner, Ropes & Gray LLP, Former Chief of Public Corruption and Special Prosecutions, United States Attorney's Office, Boston, MA

Greg Page, MD
Life Sciences Practice Head, Deloitte and Touche LLP, Jericho, NY

Edward S. Petry, PhD (Invited)
Executive Director, Ethics Officer Association, Belmont, MA

Joseph A. Piccolo
Vice President, Health Services, Fox Chase Cancer Center, Philadelphia, PA

Claudio Pincus
President, The Quantic Group, Livingston, NJ

Lori Queisser
Vice President and Chief Compliance Officer, Eli Lilly and Company, Indianapolis, IN

Owen Richards
President, The Quantic Group, Livingston, NJ

Brian Riewerts
Director, Pharmaceutical Advisory Services Group, PricewaterhouseCoopers LLP, Baltimore, MD

Dean A. Rosen
Staff of Subcommittee on Public Health, Office of Senate Majority Leader William H. Frist, MD, United States Senate, Washington, DC

Andrew Ruskin, Esq.
Vinson & Elkins, Washington, DC

Brian S. Salsberg
Associate Principal, Pharmaceutical and Medical Products Practice, McKinsey & Co., Florham Park, NJ

Catherine A. Sazdanoff
Divisional Vice President, Ethics & Compliance, Abbott Laboratories, Lake Forest, IL

Nisha Shajahan
Associate Vice President, Strategic Management Systems, Inc., Alexandria, VA

Michael Shaw
Deputy Compliance Officer, Novartis Pharmaceuticals Corporation, Former Senior Counsel, Office of the Inspector General, East Hanover, NJ

Paul J. Silver
Director, Pharmaceutical Compliance Investigative & Dispute Services, Ernst & Young LLP, Atlanta, GA

Steve Sokolow
Vice President and Head of Litigation, Novartis Pharmaceuticals Corporation, East Hanover, NJ

Melinda Somasekhar
Senior Manager, Professional Education Support Department, Wyeth Pharmaceuticals, Collegeville, PA

Shirley Stark, Esq.
Assistant Attorney General, Office of the Attorney General of New York, New York, NY

John Steer
Vice Chair, United States Sentencing Commission, Chicago, IL

T. Reed Stephens, Esq.
Partner, Sonneschein, Nath and Rosenthal, Former Trial Attorney, United States Department of Justice, Washington, DC

Davia B. Temin
President, Temin and Company, New York, NY

Philip Urofsky, Esq.
Special Counsel for International Litigation, Fraud Section, United Sates Department of Justice, Washington, DC

Sheryl Vacca
West Coast Life Science and Health Care Regulatory Practice Leader, Deloitte & Touche LLP, Los Angeles, CA

L. Stephan Vincze, Esq.
Ethics & Compliance Officer, TAP Pharmaceutical Products, Inc., Abbott Park, IL

Sally Walsh
Vice President, Federal Government Relations, GlaxoSmithKline, Washington, DC

Marc Wilenzick, Esq.
Senior Corporate Counsel, Pfizer Inc., New York, NY

Robert Wilkerson
Senior Vice President, Crisis Consulting, Marsh, Inc., Washington, DC

SPONSOR: THE PHARMACEUTICAL COMPLIANCE FORUM:

The Pharmaceutical Compliance Forum (PCF) was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs. The organization is open to others in the industry and has more than doubled in membership since its founding. The members meet twice a year, for one to two days, focusing on open and informal sharing of compliance information, best practices, and current developments in the field.

CO SPONSORED BY:
  • Association of Clinical Research Professionals
  • Food and Drug Law Institute
  • International Federation of Pharmaceutical Manufacturers Associations
  • International Pharmaceutical Privacy Consortium
  • IRB Forum
  • Pharmacy & Therapeutics (P&T) Society
  • Society of Research Administrators International (SRA)
  • The Acumen Journal of Life Sciences
  • American Pharmaceutical Review
  • BNA's Pharmaceutical Law & Industry Report
  • BNA's Medical Research Law & Policy Report
  • CenterWatch Monthly Newsletter
  • Clinical Trials Advisor
  • Drug and Market Development Publications
  • FDACompliance.Net
  • FDA News
  • Genaissance Health Care Partners
  • Harvard Health Policy Review
  • Health Affairs
  • Human Research Report
  • JobWatch Clinical Research Careers Monitor
  • Journal of Pharmaceutical Development and Regulation
  • Med Ad News
  • Pharma Marketing Network
  • Pharma Marketing News
  • Pharma Privacy Watch
  • PharmaVOICE
EXHIBIT & SPONSORSHIP INFORMATION:

For sponsorship and exhibit information review the Promotional Opportunities pages on the Congress website: www.PharmaCongress.com/promotional/index.html or contact:

REGISTRATION INFORMATION:

For further registration info, go to the Congress website at www.pharmacongress.com/registration.html, call 800-684-4549, email: registration@hcconferences.com, or write:

    Pharma Congress Office
    7790 Barberry Ave.
    Yucca Valley, CA USA 92284